This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ThousandOaks-based biotech company Capsida Biotherapeutics says it has opened up a new, 15,000 square-foot facility in ThousandOaks for its gene therapy manufacturing efforts. The company says that building its own manufacturing facility will help it eliminate dependence on ontract manufacturing.
ThousandOaks- and Shanghai-based ThousandOaks Biopharmaceuticals , a new contract manufacturing organization fort he biotech industry, said it has received $45M in a Series A financing round. The company's Chairman is Shun Luo, Ph.D.,
ThousandOaks-based Amgen said this morning that it has acquired Turkish pharmaceuticals firm Mustafa Nevzat Pharmaceuticals. Amgen said the deal is worth $700M in cash. Amgen said the acquisition will help to significantly expand its presence in Turkey.
ThousandOaks-based biotech giant Amgen said late Monday that it is donating $1M to the Japanese disaster relief efforts. The firm said it has longtime links to Japanese companies, and particularly its partnerships with Kirin Holding, Kyowa Hakko Kirin, Takeda Pharmaceuticals, and Daiichi Sankyo.
in a deal worth approximately $950M, the two companies said this morning. Move has operations in the ThousandOaks, California area, although it is now based in San Jose. The company was started in ThousandOaks in 1993, and now has 913 employees. Move, Inc. , According to the two, News Corp. READ MORE>>.
ThousandOaks-based wireless hardware provider Xirrus has raised yet another $10M in funding, according to a regulatory filing from the company Monday. Details on the funding have not yet been announced by the company. The company apparently is targeting a little over $11.0M Venture Partners. READ MORE>>.
According to Newegg, it will launch a pop-up store from August 16-18th in ThousandOaks, California, at The Oaks shopping center. The store is the company''s first, ever pop-up store. Newegg said the pop-up store will feature products from Intel, Samsung, Sony, WD and other companies. READ MORE>>.
SocialBios allows companies and individuals to create interactive "About" pages, which integrate Facebook, LinkedIn, Twitter, Facebook, and other sites. Move is based in Campbell, California, with operations in ThousandOaks. Financial terms of the acquisition were not disclosed. Socialbios is based in Denver. READ MORE>>.
It might be, on news that Kevin Sharer , the former CEO of ThousandOaks-based Amgen , has joined venture capital investment firm Foundation Medical Partners. Is Amgen the next source of the healthcare industry's venture capital deals? READ MORE>>.
ThousandOaks-based biotech giant Amgen said Monday afternoon that it is acquiring Biovex , a Woburn, Massachusetts-based developer of treatments for melanoma and head and neck cancer. BioVex develops OncoVEX, a novel oncolytic vaccine in Phase 3 clinical development.
ThousandOaks-based Amgen and venture firm Kleiner Perkins Caufield & Byers have put their backing behind a new, Westlake Village based drug development firm, Atara Biotherapeutics , in an unusual spinout of technology from the biotech giant. The new company will be headed by Isaac Ciechanover, M.D.,
ThousandOaks-based Servoy , a developer of software for developing software-as-a-service applications, said Monday that it has upgraded its namesake platform.
The latest ranking the fastest growing companies in the nation by Inc. magazine, has 42 companies in the Los Angeles area on the list. 500 companies) and New York City (42 companies) in the Inc. 500 listing, well above San Francisco (19 companies). Interestingly enough, among the top Inc.
Xirrus , the wireless hardware provider based in ThousandOaks, has just raised $10.1M funding, according to a regulatory filing by the company. Details on the funding have not yet been announced by the company. in a funding round, part of an ongoing $11.0M
ThousandOaks-based biotech Amgen is acquiring Iceland-based deCODE Genetics , in a deal worth $415M in cash, the two companies announced this morning. deCODE Genetics is a provider of human genetic research which was founded in 1996.
The news for employees over at ThousandOaks-based Amgen got worse on Tuesday, after the company said it is deepening job cuts, and plans to now cut 20 percent of its employees as part of previously announced cutbacks at the company.
Los Angeles-based NantWorks , the umbrella technology development organization run by billionaire Dr. Patrick Soon-Shiong, said today that it has launched a new immuno-oncology company called NantCell. Financial details of the deal with Amgen were not disclosed. AMG 479 had been in Phase 3 development, aimed at treating pancreatic cancer.
Amgen Ventures , the venture capital arm of ThousandOaks-based Amgen , has re-upped on an investment in a biopharmaceuticals developing microRNA-based treatments for cardiovascular and muscle disease. and Broadview Ventures. miRagen is based in Boulder, Colorado.
ThousandOaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. According to Seattle-based Theraclone Sciences , Amgen Ventures was one of the investors in a $10.6M, Series B extension round for the company.
ThousandOaks-based Amgen said on Thursday afternoon that it has taken a 20.5 percent stake in BeiGene , a research-based, oncology-focused biotechnology company in China. According to Amgen, it paid approximately $2.7 billion in cash for the stake in BeiGene, which it says it will use to expand its oncology presence in China.
ThousandOaks-based biotech giant Amgen announced Sunday that it has acquired San Francisco biopharmaceuticals company Onyx Pharmaceuticals , in a deal worth $10.4 Onyx is a developer of biopharmaceuticals used to help patients with cancer. Amgen said it will pay $125 per share inc ash for Onyx Pharmaceuticals.
ThousandOaks-based biotech giant Amgen said Friday that it has named R. Amgen cited Williams'' academic medicine background and experience in the industry as being of value to the company. Amgen cited Williams'' academic medicine background and experience in the industry as being of value to the company. READ MORE>>.
ThousandOaks-based Teledyne Technologies said this morning that it has increased its stake in Optech Incorporated , from 19 percent to 51 percent of the company. Financial terms of the deal were not announced. The transaction came from Teledyne's subsidiary, Teledyne DALSA, Inc.
ThousandOaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. According to the company, the funding came from Ally Bridge Group.
ThousandOaks-based Servoy , a developer of software for creating web-based applications, said Friday that the firm has upgraded its products. The firm said its product allows companies to build software applications that run both through a browser and through native desktop applications.
The long list of Southern California high tech companies lined up for the public markets just got a little longer this morning, with the addition of Inphi Corp. So far, two companies-- Woodland Hills-based ReachLocal , which completed its IPO in May, and Carlsbad-based Maxlinear , which hit the markets in March, have had successful IPOs.
ThousandOaks-based Nexsan , a developer of data storage systems, has delayed its IPO, according to its underwriter, Thomas Weisel Partners. The firm's IPO was being underwritten by Thomas Weisel Partners, Lazard Capital Markets, Needham & Company, and Morgan Keegan & Company. and $12.00 READ MORE>>.
ThousandOaks-based Teledyne Technologies has acquired laboratory automation and instrument developer CETAC Technologies , the company annoucned this morning. Financial details of the buy were not announced.
ThousandOaks-based electronics, aerospace, defense, and engineering products firm Teledyne said Friday morning that it has completed its acquisition of Denmark-based Reson A/S. Teledyne said the acquired company will become Teledyne RESON. Teledyne had originally announced its acquisition of RESON on January 29th.
ThousandOaks-based energy crop developer Ceres , which develops agriculutural biotechnology for the renewable fuels market, said Tuesday that Richard Flavell, PhD., Flavell remains on the company's board. The company said the new position makes Flavell a consultant to the company.
Amgen Ventures , the venture capital arm of ThousandOaks-based Amgen , has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes.
ThousandOaks-based Teledyne Technologies said Tuesday that it has named Anna Segobia Masters as its new Vice President of Human Resources, and Deputy General Counsel. Masters joins the company from Winston Strawn LLP, where she had a practice in labor and employment litigation.
ThousandOaks-based Xirrus , the developer of wireless networking hardware, announced this morning that it has appointed Adriano Lima as its new Regional Vice President for its Latin America Region. The company, which makes switched, wireless access points, said that Lima has previously served as Latin America General Manager at CA.
ThousandOaks-based biopharmaceuticals developer Amgen said yesterday that it has named Greg C. The company said that Garland will also serve on its Governance and Nominating Committee and the Audit Committee of its board. Garland also has served at COnocoPhillips and Chevron Phillips Chemical Company. READ MORE>>.
ThousandOaks-based Teledyne Technologies said Thursday that it has scored a major, marine defense electronics contract, as part of a U.S. The company said the contract is the largest single award for Teledyne DGO in its fifty year history. Navy submarine program. Teledyne did not say how much the contract was worth.
San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from ThousandOaks-based Teledyne , the companies said this morning. Financial terms of the investment were not disclosed. According to Teledyne, the investment also included a strategic partnership deal.
ThousandOaks-based Ceres , which develops specialized seeds for the biofuels industry, is planning to hit the market on February 9th, according to the NASDAQ IPO calendar. If successful, the offering will raise $132.25M for the company. Ceres recently estimated its IPO pricing at between $21.00 and $23.00
ThousandOaks-based biotech giant Amgen announced this morning that it has appointed Jonathan M. According to Amgen, Peacock joins from Novartis Pharmaceuticals AG, where he was CFO and Administrative Officer since 2005, and also has served at McKinsey and COmpany and Price Waterhouse. Peacock as Chief Financial Officer.
ThousandOaks-based Amgen announced this morning that it has named Robert A. Bradway has been at Amgen since 2006, and was most recently Executive Vice President and Chief Financial Officer at the company. Bradway as the firm's President and Chief Operating Officer. Bradway also has served at Morgan Stanley.
ThousandOaks-based Xirrus , the developer of high performance wireless networking equipment, is tapping into Relayware , a provider of collaboration and communicaitons software as part of its sales efforts, the firms said Thursday. Financial details of the link were not announced by the companies. READ MORE>>.
ThousandOaks-based electronics, aerospace, defense, and instrumentation company Teledyne Technologies said late Wednesday that Robert (Bob) W. Steenberge, the company''s vice president and Chief Technology Officer, is retiring at the end of the year. Steenberge will continue to serve as a consultant to the company.
ThousandOaks-based Teledyne Technologies said this week that it has scored a big contract, from its Teledyne Oil & Gas Group. The contract award is associated with a subsea production system off the coast of Angola.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content